Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:37 PM
Ignite Modification Date:
2025-12-24 @ 3:37 PM
NCT ID:
NCT04042792
Eligibility Criteria:
Inclusion Criteria:
* Confirmed diagnosis of a juvenile idiopathic Arthritis (JIA), uveitis or chronic recurrent multifocal osteomyelitis (CRMO)
* Medical indication for initiation of ADA treatment or established ADA therapy for ≥ 12 weeks
* Exclusion of chronic infections
* No parallel treatment with other biologic medications
* Available patient history since ADA start
* No pregnancy
* Ability to comply with the entire study protocol
* Willingness to participate with signed informed consent
Exclusion Criteria:
* Other rheumatic inflammatory diseases
* Age \< 2 years or \>18 years
* PiRD patients and parents with cognitive impairments preventing to understand study requirements
* Additional severe chronic disease (kidney failure, liver insufficiency), malignancies or prior chemotherapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
18 Years
Study:
NCT04042792
Study Brief:
Protocol Section:
NCT04042792